A citation-based method for searching scientific literature




Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann, Waheed Jamal, Karen Kimura, Janet Schnee, Cordula Zeller, Daniel Cotton, Edimar Bocchi, Michael Böhm, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure, Nadia Giannetti, Stefan Janssens, Jian Zhang, Jose R Gonzalez Juanatey, Sanjay Kaul, Hans-Peter Brunner-La Rocca, Bela Merkely, Stephen J Nicholls, Sergio Perrone, Ileana Pina, Piotr Ponikowski, Naveed Sattar, Michele Senni, Marie-France Seronde, Jindrich Spinar, Iain Squire, Stefano Taddei, Christoph Wanner, Faiez Zannad. N Engl J Med 2020
Times Cited: 615




List of shared articles



Times cited

Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy.
Biff F Palmer, Deborah J Clegg. Clin J Am Soc Nephrol 2021
1

Life-Threatening Complications Related to Delayed Diagnosis of Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Report of 2 Cases.
Shunsaku Goto, Jun-Ya Ishikawa, Masafumi Idei, Masahiro Iwabuchi, Motoki Namekawa, Takeshi Nomura. Am J Case Rep 2021
0


Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases.
Gaurav S Gulsin, Matthew P M Graham-Brown, Iain B Squire, Melanie J Davies, Gerry P McCann. Heart 2021
0

Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience.
K Zwart, S Velthuis, Y V Polyukhovych, A Mosterd, L Smidt, E H Serné, D H van Raalte, P J M Elders, M L Handoko, P C Oldenburg-Ligtenberg. Neth Heart J 2021
1

[Gliflozins-in future cardioprotective drugs?]
Ursula Rauch-Kröhnert, Ulf Landmesser. Internist (Berl) 2021
0

Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?
Abhinav Sharma, Haya Aziz, Subodh Verma, Beth L Abramson, Richard Choi, Grace L Chua, Kim A Connelly, George Honos, G B John Mancini, Sarah A Ramer,[...]. Curr Opin Cardiol 2021
0

Diabetic proximal tubulopathy: Can we mimic the disease for in vitro screening of SGLT inhibitors?
João Faria, Karin G F Gerritsen, Tri Q Nguyen, Silvia M Mihaila, Rosalinde Masereeuw. Eur J Pharmacol 2021
0

SGLT2 Inhibition by Dapagliflozin Attenuates Diabetic Ketoacidosis in Mice with Type-1 Diabetes.
Huan Chen, Yochai Birnbaum, Regina Ye, Hsiu-Chiung Yang, Mandeep Bajaj, Yumei Ye. Cardiovasc Drugs Ther 2021
0


Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy.
Melissa-Rosina Pasqua, Michael A Tsoukas, Ahmad Haidar. J Diabetes Sci Technol 2021
0

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes.
Guntram Schernthaner, Naim Shehadeh, Alexander S Ametov, Anna V Bazarova, Fahim Ebrahimi, Peter Fasching, Andrej Janež, Péter Kempler, Ilze Konrāde, Nebojša M Lalić,[...]. Cardiovasc Diabetol 2020
15